A Study of STSA-1002 in Healthy Subjects

Clinical trial NCT05497635 · COMPLETED

Trial details

NCT number: NCT05497635
Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subject

Start date: 2022-10-14
Primary completion: 2023-04-06
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.